Active Biotech to present at SG Cowen & Co 5th Annual Global Health Care Conference
The conference will give institutional investors direct contact with dynamic emerging companies. From Active Biotech will be present; Sven Andréasson CEO and Tomas Leanderson CSO.
The presentation, scheduled to take place on Wednesday, November 17 at 8:00-8:30am will cover Active Biotech's ongoing clinical development projects within the areas of autoimmunity/inflammation and cancer. A live and archived webcast will be available at www.activebiotech.com
and at www.sgcowen.com.
For more details about Active Biotech and ongoing projects, please visit our web page www.activebiotech.com
Lund, November 15, 2004
Active Biotech AB (publ)
President & CEO
Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/inflammatory diseases and cancer. Most advanced projects include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases, as well as a novel concept for use in cancer immunotherapy.
Active Biotech AB
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 20 50